Auta J., Faust W.B., Lambert P., Guidotti A., Costa E., Moerschbaecher J.M.
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Medical Center, New Orleans, Louisiana, USA.
Behav Pharmacol. 1995 Jun;6(4):323-332.
Two baselines involving a repeated acquisition task were used to assess the effects of bretazenil, imidazenil, and triazolam. The first baseline was a multiple schedule of repeated acquisition and performance of conditional discriminations. In the first component, the subject acquired a four-response chain by responding sequentially on three keys in the presence of different combinations of colors and geometric forms displayed on a center key. Acquisition of the discrimination was defined by a decrease in errors as the session progressed. In the performance component, the four-response chain was the same each session. Incorrect responses in either component produced a 5s time out during which responding had no programmed consequence. The second procedure, which has been used to evaluate the effects of drugs on memory, involved the acquisition of a discrimination, followed by a 1h delay and a retest of the same discrimination to assess retention. Triazolam (0.32 and 0.56mg/kg) administered alone, produced dose-related decreases in response rate in each component. In addition, triazolam also produced a dose-related increase in percentage errors in acquisition with no effect in performance. Triazolam (0.32mg/kg) eliminated retention (0 percent savings) in the memory task. Bretazenil (0.1-5.6mg/kg) or imidazenil (0.1-1.8mg/kg) administered alone had little or no effect on either rate of responding or accuracy in either component. Furthermore, bretazenil but not imidazenil disrupted retention at the higher doses tested. The combination of imidazenil or bretazenil with triazolam produced dose-related attenuation of the disruptive effects of triazolam on both behavioral baselines. These data suggest that the disruptive effects of benzodiazepines on learning and memory may be a function of the intrinsic efficacy of these compounds at different GABA(A) receptor subtypes.
采用两个涉及重复习得任务的基线来评估溴替唑仑、咪达唑仑和三唑仑的效果。第一个基线是重复习得和条件辨别表现的多重程序。在第一个部分,受试者通过在中心键上呈现不同颜色和几何形状组合时依次对三个键做出反应来习得一个四反应链。辨别能力的习得通过随着实验进程错误减少来定义。在表现部分,每个实验阶段的四反应链都是相同的。任何一个部分的错误反应都会导致5秒的暂停,在此期间反应没有设定的结果。第二个程序已被用于评估药物对记忆的影响,包括习得一种辨别,随后延迟1小时,然后对相同的辨别进行重新测试以评估记忆保持情况。单独给予三唑仑(0.32和0.56mg/kg)会使每个部分的反应率出现剂量相关的下降。此外,三唑仑还会使习得过程中的错误百分比出现剂量相关的增加,而对表现没有影响。三唑仑(0.32mg/kg)消除了记忆任务中的记忆保持(节省率为0%)。单独给予溴替唑仑(0.1 - 5.6mg/kg)或咪达唑仑(0.1 - 1.8mg/kg)对任何一个部分的反应率或准确性几乎没有影响。此外,在测试的较高剂量下,溴替唑仑而非咪达唑仑会破坏记忆保持。咪达唑仑或溴替唑仑与三唑仑联合使用会使三唑仑对两个行为基线的破坏作用出现剂量相关的减弱。这些数据表明,苯二氮䓬类药物对学习和记忆的破坏作用可能是这些化合物在不同GABA(A)受体亚型上的内在效力的函数。